Lumenis Reaches New 52-Week Low at $8.17 (LMNS)
Shares of Lumenis (NASDAQ:LMNS) reached a new 52-week low on Monday , Analyst RN reports. The company traded as low as $8.17 and last traded at $8.32, with a volume of 81,452 shares trading hands. The stock had previously closed at $8.83.
LMNS has been the subject of a number of recent research reports. Analysts at Zacks initiated coverage on shares of Lumenis in a research note on Wednesday, April 16th. They set a “hold” rating on the stock. Separately, analysts at Wells Fargo & Co. reiterated a “buy” rating on shares of Lumenis in a research note on Monday, April 14th. They now have a $0.53 price target on the stock. Finally, analysts at Jefferies Group initiated coverage on shares of Lumenis in a research note on Tuesday, April 8th. They set a “buy” rating and a $16.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $11.88.
The stock has a 50-day moving average of $10.80 and a 200-day moving average of $11.03. The company has a market cap of $288.2 million and a P/E ratio of 15.22.
Lumenis Ltd. is a provider of energy-based, minimally invasive clinical solutions. The Company operated in three segments: surgical, ophthalmic and aesthetic.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.